Search research articles
Contact Us
Filters
Showing results (51-60 of 60) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 60 results.
United European Gastroenterology Journal
|
June 15, 2021
European guideline on indications, performance and clinical impact of <sup>13</sup> C-breath tests in adult and pediatric patients: An EAGEN, ESNM, and ESPGHAN consensus, supported by EPC
Jutta Keller, Heinz F Hammer, Paul R Afolabi, et al.
Journal of Cancer Research and Clinical Oncology
|
December 30, 2017
CabaGast: multicentre, Phase II study with cabazitaxel in previously treated patients with advanced or metastatic adenocarcinoma of the esophagogastric junction and stomach
Harald Schmalenberg, Salah-Eddin Al-Batran, Claudia Pauligk, et al.
Future Oncology (London, England)
|
February 20, 2019
KEYNOTE-585: Phase III study of perioperative chemotherapy with or without pembrolizumab for gastric cancer
Yung-Jue Bang, Eric Van Cutsem, Charles S Fuchs, et al.
Cancers
|
September 10, 2021
Landscape of Biomarkers and Actionable Gene Alterations in Adenocarcinoma of GEJ and Stomach-A Real World Data Analysis
Louisa Hempel, Julia Veloso de Oliveira, Andreas Gaumann, et al.
International Journal of Cancer
|
April 28, 2020
Phase III randomized, double-blind study of paclitaxel with and without everolimus in patients with advanced gastric or esophagogastric junction carcinoma who have progressed after therapy with a fluoropyrimidine/platinum-containing regimen (RADPAC)
Sylvie Lorenzen, Jorge Riera Knorrenschild, Claudia Pauligk, et al.
Nature Communications
|
February 27, 2026
First-line modified FOLFOX plus/minus nivolumab and Ipilimumab or FLOT plus nivolumab in advanced gastroesophageal adenocarcinoma: a phase II multi-cohort trial
Sylvie Lorenzen, Thorsten Oliver Goetze, Peter C Thuss-Patience, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
October 23, 2023
Thyroid hormone receptor alpha modulates fibrogenesis in hepatic stellate cells
Paul Manka, Jason D Coombes, Svenja Sydor, et al.
Clinical Nutrition ESPEN
|
June 26, 2025
Individually compounded multi-chamber vs. standardized parenteral nutrition bags in solid tumors-A randomized clinical trial (IKF-010)
Thorsten Oliver Goetze, Ralf-Dieter Hofheinz, Ingeborg Roetzer, et al.
European Journal of Human Genetics : EJHG
|
December 26, 2025
Exome sequencing points to pathogenic ATM variants in gastric cancer
Laura L Koebbe, Timo Hess, Stephan L Haas, et al.
Ebiomedicine
|
May 20, 2023
Dissecting the genetic heterogeneity of gastric cancer
Timo Hess, Carlo Maj, Jan Gehlen, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 60) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 60 results.
United European Gastroenterology Journal
|
June 15, 2021
European guideline on indications, performance and clinical impact of <sup>13</sup> C-breath tests in adult and pediatric patients: An EAGEN, ESNM, and ESPGHAN consensus, supported by EPC
Jutta Keller, Heinz F Hammer, Paul R Afolabi, et al.
Journal of Cancer Research and Clinical Oncology
|
December 30, 2017
CabaGast: multicentre, Phase II study with cabazitaxel in previously treated patients with advanced or metastatic adenocarcinoma of the esophagogastric junction and stomach
Harald Schmalenberg, Salah-Eddin Al-Batran, Claudia Pauligk, et al.
Future Oncology (London, England)
|
February 20, 2019
KEYNOTE-585: Phase III study of perioperative chemotherapy with or without pembrolizumab for gastric cancer
Yung-Jue Bang, Eric Van Cutsem, Charles S Fuchs, et al.
Cancers
|
September 10, 2021
Landscape of Biomarkers and Actionable Gene Alterations in Adenocarcinoma of GEJ and Stomach-A Real World Data Analysis
Louisa Hempel, Julia Veloso de Oliveira, Andreas Gaumann, et al.
International Journal of Cancer
|
April 28, 2020
Phase III randomized, double-blind study of paclitaxel with and without everolimus in patients with advanced gastric or esophagogastric junction carcinoma who have progressed after therapy with a fluoropyrimidine/platinum-containing regimen (RADPAC)
Sylvie Lorenzen, Jorge Riera Knorrenschild, Claudia Pauligk, et al.
Nature Communications
|
February 27, 2026
First-line modified FOLFOX plus/minus nivolumab and Ipilimumab or FLOT plus nivolumab in advanced gastroesophageal adenocarcinoma: a phase II multi-cohort trial
Sylvie Lorenzen, Thorsten Oliver Goetze, Peter C Thuss-Patience, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
October 23, 2023
Thyroid hormone receptor alpha modulates fibrogenesis in hepatic stellate cells
Paul Manka, Jason D Coombes, Svenja Sydor, et al.
Clinical Nutrition ESPEN
|
June 26, 2025
Individually compounded multi-chamber vs. standardized parenteral nutrition bags in solid tumors-A randomized clinical trial (IKF-010)
Thorsten Oliver Goetze, Ralf-Dieter Hofheinz, Ingeborg Roetzer, et al.
European Journal of Human Genetics : EJHG
|
December 26, 2025
Exome sequencing points to pathogenic ATM variants in gastric cancer
Laura L Koebbe, Timo Hess, Stephan L Haas, et al.
Ebiomedicine
|
May 20, 2023
Dissecting the genetic heterogeneity of gastric cancer
Timo Hess, Carlo Maj, Jan Gehlen, et al.
Page
of 6